23/05/2022.
As observed by Dr Eline Noels of the Erasmus University of Rotterdam, the knowledge of the economic burden of skin cancers is “essential to enable health policy decision-makers to make well-informed decisions on potential interventions and to be able to evaluate the future effect of these decisions”.
Currently there is a lack of comprehensive and updated studies providing a quantitative and updated assessment of the economic burden of skin cancers; it is true particularly for non-melanoma skin cancers due to poor collection of registered data.
Keep reading at Economic burden of skin cancers in Europe.